Companies – Summaries Facts
M Health Care (NYSE: MMM) announced the introduction of a full line of new, innovative
Tegaderm™ High Performance Foam Adhesive Dressings. In clinical and laboratory tests, these new adhesive foam wound dressings outperform other leading foam adhesive dressings in managing the full range of low- to high-moisture conditions that can be present in chronic and acute wounds.
3M has completed its acquisition of PolyFab Inc., a manufacturer of thermal and acoustic insulation for the aerospace industry. MTI PolyFab designs and manufactures a light-weight thermal and acoustic insulation system for a wide variety of aerospace customers to address unwanted airborne and struc- ture-borne noise in aircraft. The combination of MTI PolyFab products with those of 3M’s wholly-owned subsidiary, Aearo Technologies LLC, will provide a comprehensive range of solutions to the aerospace industry.
ap Implantate AG, a German medical techno- logy company, achieved in the first quarter of the
fiscal year 2010 sales at product level of EUR5.7 mil- lion. Disregarding project sales, sales in the Analytics division that was sold in December 2009, and other one-time factors totaling EUR2.4 million, compara- ble product sales in the first quarter of 2009 were EUR5.9 million. That leaves Q1 2010 sales EUR 0.2 million, or 3%, down on Q1 2009. http://www.aap.de
full year ended March 31, 2010. Revenue for the quarter increased 4% to $20.8 million from $20.0 million for the same quarter of the previous year. Revenue for the year ended March 31, 2010 incre- ased 2% to $83.0 million from $81.0 million for the previous year. Non-GAAP net loss was ($0.6) million, or ($0.02) per diluted share, for the three months en- ded March 31, 2010 compared to ($1.5) million, or ($0.05) per diluted share, for the same quarter of the previous year. Non-GAAP net income was $6.6 mil- lion, or $0.24 per diluted share, for the year ended March 31, 2010 compared to $6.0 million, or $0.22 per diluted share, for the previous year.
The Company’s balance sheet as of March 31, 2010 included cash, cash equivalents, marketable secu- rities and restricted cash of $93.1 million. Deferred revenue at the end of the fourth quarter was $61.3 million, up 7% from March 31, 2009. The Company has no debt outstanding. http://www.accelrys.com
rage systems for clean, efficient power and energy management, reported financial results for the first quarter ended March 31, 2010.
Recent Highlights • Continued Altair‘s long-term supply relationship
ltair Nanotechnologies, Inc. (Altairnano, NASDAQ: ALTI), a provider of energy sto-
ccelrys, Inc. (NASDAQ: ACCL) reported financial results for the fourth fiscal quarter and
10-05/06 :: May/June 2010